Active
Overview
- Legal name
- IDT BIOLOGIKA GMBH
- Registered location
- DESSAU-ROSSLAU, DEU
- Website
- Company website ↗
- Primary NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- Latest award activity
- Sep 23, 2025
Read company summary
IDT BIOLOGIKA GMBH is associated with UEI E14GD5J873N9 and CAGE D3395 in public federal records. AcornBids currently links 7 prime awards totaling $12.4M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325414 (Biological Product (except Diagnostic) Manufacturing). Its public SAM.gov registration lists DESSAU-ROSSLAU, DEU.
At a glance
Lifetime prime obligations$12.4M
Prime awards7
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 10, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- IDT BIOLOGIKA GMBH
- UEI
- E14GD5J873N9
- CAGE
- D3395
- Registered address
- AM PHARMAPARK, DESSAU-ROSSLAU, DEU
- Registration status
- Active
- Primary NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- SAM activation
- Feb 6, 2026
- Initial registration
- Apr 25, 2016
- Entity start
- Dec 4, 1985
- SAM updated
- Feb 6, 2026
- Registration expires
- Feb 6, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DEU
Research brief
Source facts
- Loaded prime-award records link 7 awards and $12,434,525 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: IDT BIOLOGIKA BASE AWARD FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID 19 CAN 844363 $20,462.00 Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$4.1M
Prime contracts
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 7 of 7 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93020F00002IDT BIOLOGIKA BASE AWARD FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID 19 CAN 844363 $20,462.00 | Department of Health and Human Services | $554.3K | May 8, 2020 | May 17, 2025 |
| 75N93023F00001MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2. | Department of Health and Human Services | $4.2M | Sep 26, 2023 | May 14, 2028 |
| 75N93019F003111800011I IDT BIOLOGIKA VACCINE MANUFACTURING AND CHARACTERIZATION SERVICES TO VM19V8RDB--3 QUANTITY BASE AWARD IID CAN 8470036 $367,000.00 | Department of Health and Human Services | $2.7M | Aug 19, 2019 | Apr 18, 2025 |
| 75N93020F00001IDT BIOLOGIKA BASE FY20 PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 CAN 8044363 TOTAL $20,462.00 | Department of Health and Human Services | $20.5K | May 8, 2020 | Apr 17, 2024 |
| 75N93020F00003CONTRACT #HHSN272201800011I IDT BIOLOGIKA DEVELOPMENT AND MANUFACTURE OF TOXOID FUSION 3XSTAN12SMNLTR192GL211A AND CF,I,II,IV MASTER BANKS CAN 8470038 TOTAL $555,600.00 | Department of Health and Human Services | $1.2M | Sep 17, 2020 | Apr 30, 2024 |
| 75N93021F00001CONTRACT #HHSN272201800011I IDT BIOLOGIKA FY21 PROCESS DEVELOPMENT AND MASTER BANK PRODUCTION FOR A STAPH AUREUS, SPA | Department of Health and Human Services | $1.1M | Aug 19, 2021 | Apr 18, 2025 |
| 75N93024F00001HHSN272201800011I IDT BIOLOGIKA MASTER CELL BANKS MANUFACTURING FOR NEXT GENERATION SARS-COV-2 VACCINES | Department of Health and Human Services | $2.6M | May 15, 2018 | Apr 18, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 6, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Apr 25, 2016 |
| Entity start | Dec 4, 1985 |
| Industry | Reported size status |
|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ARMAND MOELLER | Government business | Contact method not published | SAM registration | Not available |
| MARVIN KRIX | Electronic business | Contact method not published | SAM registration | Not available |
| STEFAN SCHMELZ | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325414 — Biological Product (except Diagnostic) Manufacturing
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
1 awards
1 awards
1 awards
About IDT BIOLOGIKA GMBH
What products and services appear in its federal awards?
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
- IDT BIOLOGIKA BASE AWARD FY20 MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS COVID 19 CAN 844363 $20,462.00
- MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2.
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
AM PHARMAPARK, DESSAU-ROSSLAU, DEU
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325414 — Biological Product (except Diagnostic) Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit